M. Padrines

502 total citations
9 papers, 417 citations indexed

About

M. Padrines is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, M. Padrines has authored 9 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in M. Padrines's work include Bone health and treatments (4 papers), Bone Metabolism and Diseases (4 papers) and Protease and Inhibitor Mechanisms (2 papers). M. Padrines is often cited by papers focused on Bone health and treatments (4 papers), Bone Metabolism and Diseases (4 papers) and Protease and Inhibitor Mechanisms (2 papers). M. Padrines collaborates with scholars based in France and United Kingdom. M. Padrines's co-authors include Dominique Heymann, Sandrine Théoleyre, Françoise Rédiní, Frédéric Blanchard, Yohann Wittrant, Yannick Fortun, Carmen Ruiz Velasco, Marc Baud’huin, Laurence Duplomb and Sylvie Ricard‐Blum and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Infection and Immunity and Bone.

In The Last Decade

M. Padrines

8 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Padrines France 7 274 232 64 60 56 9 417
Stephen H. Schilling United States 8 404 1.5× 108 0.5× 46 0.7× 86 1.4× 49 0.9× 10 555
Jun-ichi Imai Japan 9 287 1.0× 116 0.5× 72 1.1× 69 1.1× 28 0.5× 10 521
Madoka Hayashi Japan 4 378 1.4× 210 0.9× 91 1.4× 87 1.4× 114 2.0× 7 507
Julie Chesneau France 11 192 0.7× 155 0.7× 66 1.0× 45 0.8× 21 0.4× 16 347
Antonio R.G. Susperregui Spain 8 363 1.3× 138 0.6× 58 0.9× 90 1.5× 29 0.5× 8 486
Mitsuhiro Hoshijima Japan 9 628 2.3× 232 1.0× 111 1.7× 90 1.5× 38 0.7× 18 708
Kazuki Omoteyama Japan 14 288 1.1× 72 0.3× 68 1.1× 75 1.3× 20 0.4× 32 434
Athanasios Stratis Germany 7 270 1.0× 106 0.5× 93 1.5× 129 2.1× 84 1.5× 8 583
Eílis Foran Ireland 5 186 0.7× 91 0.4× 52 0.8× 14 0.2× 60 1.1× 5 359
L Danks United Kingdom 5 213 0.8× 176 0.8× 43 0.7× 85 1.4× 60 1.1× 7 379

Countries citing papers authored by M. Padrines

Since Specialization
Citations

This map shows the geographic impact of M. Padrines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Padrines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Padrines more than expected).

Fields of papers citing papers by M. Padrines

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Padrines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Padrines. The network helps show where M. Padrines may publish in the future.

Co-authorship network of co-authors of M. Padrines

This figure shows the co-authorship network connecting the top 25 collaborators of M. Padrines. A scholar is included among the top collaborators of M. Padrines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Padrines. M. Padrines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Verrecchia, Franck, et al.. (2012). Role of adam12 in osteosarcoma development and in TGFΒ/SMAD pathway activity. Bone. 50. S183–S184.
2.
Velasco, Carmen Ruiz, Marc Baud’huin, Corinne Sinquin, et al.. (2011). Effects of a sulfated exopolysaccharide produced by Altermonas infernus on bone biology. Glycobiology. 21(6). 781–795. 24 indexed citations
3.
Velasco, Carmen Ruiz, Sylvia Colliec‐Jouault, Corinne Sinquin, Dominique Heymann, & M. Padrines. (2010). An exopolysaccharide produced by alteromonas infernus reduces lung metastasis and prolongs survival rate of osteosarcoma-bearing mice. Bone. 48(1). S42–S43. 1 indexed citations
4.
Velasco, Carmen Ruiz, et al.. (2008). Proteases and bone remodelling. Cytokine & Growth Factor Reviews. 20(1). 29–41. 38 indexed citations
5.
Baud’huin, Marc, Laurence Duplomb, Carmen Ruiz Velasco, et al.. (2007). Key roles of the OPG–RANK–RANKL system in bone oncology. Expert Review of Anticancer Therapy. 7(2). 221–232. 65 indexed citations
6.
Théoleyre, Sandrine, Patricia Vusio, Frédéric Blanchard, et al.. (2006). Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor κB ligand (RANKL) and RANK. Biochemical and Biophysical Research Communications. 347(2). 460–467. 79 indexed citations
7.
Wittrant, Yohann, Sandrine Théoleyre, M. Padrines, et al.. (2004). RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1704(2). 49–57. 191 indexed citations
8.
Rousselle, A V, Eva Grimaud, Yannick Fortun, et al.. (2001). Potential synergies between matrix proteins and soluble factors on resorption and proteinase activities of rabbit bone cells.. PubMed. 16(3). 727–34. 7 indexed citations
9.
Padrines, M. & Joseph G. Bieth. (1989). Pseudomonas aeruginosa elastase does not inactivate alpha 1-proteinase inhibitor in the presence of leukocyte elastase. Infection and Immunity. 57(12). 3793–3797. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026